References

  1. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No.5. version 2.0. Lyon: IARC Press.. Google Scholar

  2. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H. Part I: Cancer in Indigenous Africans-burden, distribution, and trends. Lancet Oncol. 2008; 9(7):683-92. PubMed | Google Scholar

  3. Denny L, Quinn M and Sankaranarayanan R. Chapter 8: Screening for cervical cancer in developing countries. Vaccine. 2006; 24 (Suppl 3):S71-S77. PubMed | Google Scholar

  4. Faridi R, Zahra A, Khan K, Idrees M. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol. 2011;8:269. PubMed | Google Scholar

  5. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. Human papillomavirus typedistribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621-632. PubMed | Google Scholar

  6. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2013; 134(6):1389-98. PubMed | Google Scholar

  7. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS.Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol.2008;168(2):123-137. PubMed | Google Scholar

  8. Cu-Uvin S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D, Mayer KH for the HIV Epidemiology Research Study Group. Prevalence of Lower Genital Tract Infections among Human Immunodeficiency Virus (HIV)-Seropositive and High-Risk HIV-Seronegative Women. Clin Infect Dis. 1999; 29(5):1145-50. PubMed | Google Scholar

  9. Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A, Faesen M, Levin S, Michelow P, Omar T, Hudgens MG, Williamson AL, Allan B, Lewis DA, Smith JS. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One. 2013; 8(1):e53494. PubMed | Google Scholar

  10. Lomalisa P, Smith T, Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. GynecolOncol. 2000; 77(3):460-463. PubMed | Google Scholar

  11. Cronjé HS. Cervical screening strategies in resourced and resource-constrained countries. Best Pract Res Clin Obstet Gynaecol. 2011; 25(5):575-84. PubMed | Google Scholar

  12. Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, Li L, Fife D. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer. 2003; 13(6):819-26. PubMed | Google Scholar

  13. Richman AR, Brewer NT, Liebman AK, Rinas AC, Smith JS. Optimising human papillomavirus self-testing for high risk women. Sex Transm Infect. 2011; 87(2):118-122. PubMed | Google Scholar

  14. Scarinci IC, Litton AG, Garcés-Palacio IC, Partridge EE, Castle PE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues. 2013; 23(2):e123-30. PubMed | Google Scholar

  15. Arriba LN, Enerson CL, Belinson S, Novick L, Belinson J. Mexican Cervical Cancer Screening Study II: acceptability of human papillomavirus self-sampler. Int J Gynecol Cancer. 2010; 20(8):1415-23. PubMed | Google Scholar

  16. Firnhaber C, Zungu K, Levin S, Michelow P, Montaner LJ, McPhail P, Williamson AL, Allan BR, Van der Horst C, Rinas A, Sanne I. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. ActaCytol. 2009; 53(1):10-7. PubMed | Google Scholar

  17. Bhatla N, Dar L, Patro AR et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?. Cancer Epidemiol. 2009; 33(6):446-450(http://www.ncbi.nlm.nih.gov/pubmed/19931499). PubMed | Google Scholar

  18. Coutlée F, Hankins C, Lapointe N. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction - The Canadian Women's HIV Study Group. J Med Virol. 1997; 51(1):42-47. PubMed | Google Scholar

  19. Flores Y, Shah K, Lazcano E, Hernandez M, Bishai D, Ferris DG, Lorincz A, Hernandez P, Salmeron J, Morelos HPV study collaborators. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV study. SaludPublica Mex. 2002; 44(4):335-244. PubMed | Google Scholar

  20. Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, Pan QJ, Ma JF, Niyazi M, Li CQ, Li SM, Smith JS, Belinson JL, Qiao YL, Castle PE. Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method. J Natl Cancer Inst. 2012; 104(3):178-88. PubMed | Google Scholar

  21. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, Nevarez PH, Acosta RD, Hernández-Avila M. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011; 378(9806):1868-73. PubMed | Google Scholar

  22. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008; 9(10):929-936. PubMed | Google Scholar

  23. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA. HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360(14):1385-1394. PubMed | Google Scholar

  24. Lack N, West B, Jeffries D, Ekpo G, Morison L, Soutter WP, Walraven G, Boryseiwicz L. Comparison of non-invasivesamplingmethods for detection of HPV in rural African women. Sex Transm Infect. 2005; 81(3):239-41. PubMed | Google Scholar

  25. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. Prevalence and distribution of HOV genotypes among HIV-infected women in Zambia. Br J Cancer. 2007; 96(9):1480-1483. PubMed | Google Scholar

  26. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne I, Lewis DA, Williamson AL, Allan B, Williams S, Rinas A, Levin S, Smith JS. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010; 21(3):433-443. PubMed | Google Scholar

  27. Suba EJ, González-Mena LE, Arrecillas-Zamora MD, Raab SS. Self-collection of vaginal specimens for HPV testing. Lancet. 2012; 379(9826):1587-8. PubMed | Google Scholar

  28. Mitchell S, Ogilvie G, Steinberg M, Sekikubo M, Biryabarema C, Money D. Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. Int J GynaecolObstet 2011; 114(2):111-5. Google Scholar

  29. Racey CS, Withrow DR, Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health. 2013; 104(2):e159-66. PubMed | Google Scholar

  30. Denny L. Cytological screening for cervical cancer prevention. Best Pract Res ClinObstetGynaecol. 2012; 26(2):189-96. PubMed | Google Scholar

  31. Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DA, Meijer CJ. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer. 2013; 132(10):2223-36. PubMed | Google Scholar

  32. Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Retraite LL, Djoufelkit K, Heid P, Davies P, Piana L. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.. Int J Cancer. 2013; 133(11): 2681-2687. Google Scholar

  33. Leyden WA, Manos MM, Geiger AM, Wienmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Institute. 2005; 97(9):675-683. PubMed | Google Scholar